Berith Nilsson

Biochemistry, Genetics and Molecular Biology · Life Sciences

10h-index667citations16works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(9), CAR-T cell therapy research(6), Immunotherapy and Immune Responses(4), RNA Interference and Gene Delivery(3), Viral Infectious Diseases and Gene Expression in Insects(2)

Publications16 total

Systemic lupus erythematosus subgroups, with features of antiphospholipid or Sjogren's syndrome, differ in molecular signatures and treatment perspectives
Scandinavian Journal of Rheumatology·2018· 2 cited
Complement Proteins In Long-Term Weight Responders And Non-Responders After Gastric Bypass
2017
Safe engineering of <scp>CAR</scp> T cells for adoptive cell therapy of cancer using long‐term episomal gene transfer
EMBO Molecular Medicine·2016· 67 citedOpen Access
Abstract A171: Long-term episomal gene transfer for safe engineering of T cells for adoptive cell therapy of cancer
Cancer Immunology Research·2016
Tat-PTD-Modified Oncolytic Adenovirus Driven by the SCG3 Promoter and ASH1 Enhancer for Neuroblastoma Therapy
Human Gene Therapy·2013· 10 citedOpen Access
Adenovirus Serotype 5 Vectors with Tat-PTD Modified Hexon and Serotype 35 Fiber Show Greatly Enhanced Transduction Capacity of Primary Cell Cultures
PLoS ONE·2013· 29 citedOpen Access
Abstract A7: TARP-TCR-engineered T cells specifically kill HLA-A2 positive prostate and breast cancer cells.
Cancer Research·2013
T cells engineered with a T cell receptor against the prostate antigen TARP specifically kill HLA-A2 <sup>+</sup> prostate and breast cancer cells
Proceedings of the National Academy of Sciences·2012· 32 citedOpen Access
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Journal of Neuroinflammation·2012· 340 citedOpen Access
Adenovirus with Hexon Tat-Protein Transduction Domain Modification Exhibits Increased Therapeutic Effect in Experimental Neuroblastoma and Neuroendocrine Tumors
Journal of Virology·2011· 41 citedOpen Access
Double-Detargeted Oncolytic Adenovirus Shows Replication Arrest in Liver Cells and Retains Neuroendocrine Cell Killing Ability
PLoS ONE·2010· 55 citedOpen Access
649. Increased Therapeutic Efficacy of the Prostate-Specific Oncolytic Adenovirus Ad[I/PPT-E1A] by Introduction of the Entire E3 Region or the Adenovirus Death Protein
Molecular Therapy·2006Open Access
Simultaneous Generation of Cytomegalovirus‐Specific CD8<sup>+</sup>and CD4<sup>+</sup>T Lymphocytes by Use of Dendritic Cells Comodified with pp65 mRNA and pp65 Protein
The Journal of Infectious Diseases·2005· 5 cited
A Novel TARP-Promoter-Based Adenovirus against Hormone-Dependent and Hormone-Refractory Prostate Cancer
Molecular Therapy·2004· 41 citedOpen Access
Twenty Years with Monoclonal Antibodies: State of the art-Where do we go?
Acta Oncologica·1996· 19 citedOpen Access
Expression of intestinal alkaline phosphatase in human organs
Histochemistry and Cell Biology·1992· 26 cited

Frequent Co-authors

Magnus Essand(12), Di Yu(6), Chuan Jin(3), Mohanraj Ramachandran(3), Justyna Leja(3), Fredrik Eriksson(3), Björn Carlsson(3), Grammatiki Fotaki(2), Valeria Giandomenico(2), Wing‐Shing Cheng(2), Thomas H. Tötterman(2), Victoria Hillerdal(2), Chuan Jin(2), Torgny Stigbrand(2), Moa Fransson(1), Elena Piras(1), Joachim Burman(1), Binfeng Lu(1), Robert A. Harris(1), Peetra U. Magnusson(1)